Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-16 Tax Withholding |
2022-05-18 7:19 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
832 | $5.67 | 121,110 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-04 4:06 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
9,072 | $2.48 | 873,080 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-04 4:06 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
9,072 | $0 | 873,080 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-01 8:00 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
15,625 | $2.48 | 873,080 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-01 8:00 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
15,625 | $0 | 873,080 (Direct) |
View |
| 2022-02-04 Tax Withholding |
2022-02-08 9:09 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
981 | $11.4 | 873,080 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 9:09 pm |
N/A 2032-02-04 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
122,673 | $0 | 873,080 (Direct) |
View |
| 2022-01-31 Exercise |
2022-02-02 8:11 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
15,625 | $2.48 | 751,388 (Direct) |
View |
| 2022-01-31 Exercise |
2022-02-02 8:11 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
15,625 | $0 | 751,388 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 8:48 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
40,322 | $2.47 | 750,000 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 8:48 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
40,322 | $0 | 750,000 (Direct) |
View |
| 2021-04-20 Conversion |
2021-04-22 7:53 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
1,500,000 | $0 | 750,000 (Direct) |
View |
Ownership |
2021-04-15 08:56 am |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
0 | $0 | 750,000 (Direct) |
View |